<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03606798</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX2015/06</org_study_id>
    <nct_id>NCT03606798</nct_id>
  </id_info>
  <brief_title>Multidisciplinary and Personalized Care of Behavioral Disorders in Frontotemporal Lobar Degeneration.</brief_title>
  <acronym>DLFT</acronym>
  <official_title>Multidisciplinary and Personalized Care of Behavioral Disorders in Frontotemporal Lobar Degeneration.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fronto-Temporal Lobar Degeneration (FTLD) refers to 3 categories of neurodegenerative
      diseases generally occurring between 55 and 65 years: Fronto-Temporal Dementia(FTD), Primary
      Progressive Aphasia (PPA), Semantic Dementia (SD). Clinical expression is substantially
      variable among individuals, but in most cases, behavioural disorders and personality changes
      are prominent. FTLD is poorly known by general public including health care professionals.
      Currently, the French health system does not meet the needs and expectations of patients and
      their families
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with FTLD and their caregivers need to be recognized and supported through specific
      and tailored made actions provided by expert teams. The main objective of our study is to
      evaluate the effectiveness of a 6-month personalized multidisciplinary care provided to the
      dyad FTLD patient and caregiver on patient's behavioural disorders. The secondary objectives
      are to assess the impact of this program on patient's cognitive deterioration, functional
      autonomy and behavioral problems, as well as caregiver's depressive symptomatology and sense
      of competence
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 21, 2018</start_date>
  <completion_date type="Anticipated">June 21, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 21, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neuropsychiatric Inventory (NPI)</measure>
    <time_frame>6 months</time_frame>
    <description>Assessment of neuropsychiatric symptomatology</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neuropsychiatric Inventory (NPI)</measure>
    <time_frame>12 months</time_frame>
    <description>Assessment of neuropsychiatric symptomatology</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mini Mental State Examination</measure>
    <time_frame>6 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frontal Behavioral Inventory</measure>
    <time_frame>6 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frontal Assessment Battery</measure>
    <time_frame>6 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geriatric Depression Scale Score ( From 0 to 30)</measure>
    <time_frame>6 months and 12 months</time_frame>
    <description>Score : 0 - 5 : normal Score : 5 - 9 : light depression Score : 10 - 30 : severe depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sense of Competence Questionnaire (SCQ)</measure>
    <time_frame>6 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Questionnaire (QoL-AD)</measure>
    <time_frame>6 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hierarchical scale of internality for elderly people (EHIPA) score ( From 0 to 22)</measure>
    <time_frame>6 months and 12 months</time_frame>
    <description>The score varies from 0 to 22. A high score corresponding to an important internality</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Frontotemporal Lobar Degeneration</condition>
  <arm_group>
    <arm_group_label>Multidisciplinary and personalized care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Personalized care and proposals bring by a team of experts : neurologists ; geriatrician ; psychologist.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Reference care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard clinical evaluations of patient with Frontotemporal Lobar Degeneration.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>3 Home visits made by a psychologist</intervention_name>
    <description>Patient and caregiver interviews with a psychologist at home</description>
    <arm_group_label>Multidisciplinary and personalized care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

        Patients

          -  Fronto-Temporal Lobar Degeneration diagnoses

          -  Men or women aged 18 and over

        Caregiver

        • Spouse, brother, sister, child living at patient's home and can provide the medical team
        of reliable information on the status of their parent.

        Exclusion criteria :

        Patient

          -  Patient institutionalized

          -  Pregnant or breast-feeding woman

          -  Psychotic syndrome

          -  Severe and unstable general medical condition

          -  Patient bedridden

        Caregiver

          -  Persons under legal protection

          -  Severe and unstable general medical condition

          -  Pregnant or breast-feeding woman
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-François DARTIGUES</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Bordeaux</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sophie AURIACOMBE</last_name>
    <phone>05 57 82 12 53</phone>
    <email>sophie.auriacombe@chu-bordeaux.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hélène AMIEVA</last_name>
    <phone>05 57 57 15 10</phone>
    <email>helene.amieva@u-bordeaux.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bordeaux University Hospital</name>
      <address>
        <city>Bordeaux</city>
        <zip>33079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie AURIACOMBE</last_name>
      <phone>05 57 82 12 53</phone>
      <email>sophie.auriacombe@chu-bordeaux.fr</email>
    </contact>
    <contact_backup>
      <last_name>Hélène AMIEVA</last_name>
      <phone>05 57 57 15 10</phone>
      <email>helene.amieva@u-bordeaux.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>July 20, 2018</study_first_submitted>
  <study_first_submitted_qc>July 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 31, 2018</study_first_posted>
  <last_update_submitted>December 18, 2019</last_update_submitted>
  <last_update_submitted_qc>December 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Frontotemporal Lobar Degeneration</keyword>
  <keyword>Behavioral disorders</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Frontotemporal Lobar Degeneration</mesh_term>
    <mesh_term>Problem Behavior</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

